ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0014065;phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;26.42836680105094;6.343086423195323;8.845336528452411E-4;0.6993857346658935;[EDN1, PIK3CD, GATA3, PIK3C2A, PIK3R5, AKT1]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, ZFYVE16, GATA3, LYN, ABCA1, COL1A1, SRP9, MMP12, CENPF, SNX17, GOPC, NCF1, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, ARRB1, ARRB2, TNFSF13B, ITGB6, ARL4C, LCP2, LRP1, LRP2, SEC63, GOLPH3L, HNF1B, ACTN4, KIF20A, MSR1, EGR2, POLA2, TF, CD24, CD3G, AKAP12, CCR7, CD36, SYK, NAPA, HSD17B4, STX11, CD74, NEDD4, FKBP1B, RAMP1, SCARB2, ZFAND6, CARD11, ECT2, NUP155, NASP, PLEK, NUP62, YWHAH, NUP133, TBC1D9, CHI3L1, NUP54, MX2, NUP35, RAN, PHB2, HOMER3, CUBN, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, EXOC1, CCL19, NR1H4, TNF, CLU, LAMP2, TAP1, RAB32, RAB31, CALCRL, SLC15A3, DAB2, BCL6, BCL3, CCDC22, TLK1, NLGN1, UNC93B1, VPS4B, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, STRADB, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, LTBP2, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:0009395;phospholipid catabolic process;6.0;0.7248374789738407;0.6855390520770648;9.05316010758856;279.93785671288197;6.343086423195323;0.00936926813646565;0.647506047256038;[PNPLA8, ABHD12, PLCG2, PNPLA6, PLCG1]
GO:0045401;positive regulation of interleukin-3 biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.777073627680469;0.027900220892599446;0.875;[SYK]
GO:0090330;regulation of platelet aggregation;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;97.23557350837086;6.943860283624253;0.0032543871389904074;0.7513499630073597;[LYN, CEACAM1, SYK, PDPN, PRKCD, CD9, PRKCQ, ALOX12]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[TNFSF11, CCL19, MAP4K1, SYK, RIPK2, CD40LG, MDFIC, PKN1]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, PIK3CD, SLA2, PIK3C2A, FGF5, IMPA2, PDGFRB, PDGFRA, CISH, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, HBEGF, PDGFA, PIK3R3, PIK3R5, SOCS2, CD19, FYN, PIP5K1B, ICOS, TRAT1, EGF, KITLG, PIKFYVE, CD28]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[CSF1R, CD40, HDAC2, IFNA2, GHR, CCL5, FYN, IL6R, LYN, LIF, IL18, OSM, PARP9, GH1, IL6, IFNG, IL23A, KIT, HCLS1]
GO:0043069;negative regulation of programmed cell death;6.0;0.5470854108181258;0.5966630179992074;7.49501548954201;59.55619652718796;2.9592430562263194;0.001993292300667925;0.47445614010443393;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, PLCG2, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, DNAJA3, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, TEK, NAA15]
GO:0060369;positive regulation of Fc receptor mediated stimulatory signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.577230958104572;294.1477435792768;8.390779266560578;0.009844860261815976;0.7800242071602487;[LYN]
GO:0002762;negative regulation of myeloid leukocyte differentiation;8.0;0.7671156992804218;0.7585578496402109;9.352270875863963;700.1468303315412;5.948432231191374;0.02343328431995837;0.6792031009335148;[INPP5D, HOXA7, LYN, LILRB1, INHBA, LILRB3, NME1, CEACAM1, MAFB, CDK6, RARA, TRIB1, TLR4, LTF, FBN1, C1QC]
GO:0045646;regulation of erythrocyte differentiation;7.0;0.7980440201809971;0.7499413753476991;9.34084218004034;77.59787612007705;5.9928839937622085;0.002597131080184449;0.6573957313958061;[SPI1, HMGB2, GATA1, ETS1, INPP5D, NCKAP1L, HOXA5, LYN, MED1, KLF13, ISG15, INHBA, MAPK14, MAFB, CDK6, TAL1]
GO:0051090;regulation of DNA binding transcription factor activity;10.0;0.7192862368539868;0.7748841302879137;9.223059144383958;255.33763090554476;3.793137346993279;0.00854592071745993;0.6092222321850824;[GFI1, PHB2, ICAM1, AKT1, TNFSF11, CYP1B1, TRIM25, PRKCH, SFRP4, BTK, SIK1, PRKCQ, TRIB1, BEX1, TWIST1, PRKCZ, PKHD1, NHLH2, S100A12, HMOX1, FZD1, JUN, JUP, EIF2AK2, ID1, EZH2, CD40, CD36, HAVCR2, IL10, EDN1, SYK, ANXA3, RIPK2, NFAM1, IL18, FOS, SIRT1, PSMA6, HCK, IL1B, KIT, HCLS1, TLR6, SGK1, TLR4, TLR2, SP100, FLNA, NR1H4, POU4F1, NLRP12, CD40LG, FOXA2, CSF3, TNF, CLU, PYCARD, MEN1, FANCD2, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, G3BP2, NLRP3, TGFB1, WFS1, NFKB1, NFKB2, NFKBIA, IL6, COPS5, JMY, CCDC22, MYD88, CREBZF, ITGB2, TNFAIP3, ARRB1, ARRB2, MYOCD, CHUK, DDX58, IRAK3, TRAF1, GREM1, XCL1, LTF, HDAC2, NLRC3, NLRC4, NOD2, KLF4]
GO:0010812;negative regulation of cell-substrate adhesion;6.0;0.7980440201809971;0.722142322680643;9.117698628726131;52.01138116012746;5.769740442447999;0.001740774120225403;0.618185107137305;[SERPINE1, TACSTD2, FBLN1, ARHGAP6, THBS1, LGALS1, HOXA7, MEN1, POSTN, JAG1, ACTN4, COL1A1, BCL6, DLC1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, STAT4, SPP1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, RUVBL2, ADCYAP1, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, ARRB1, HHEX, PPP1R12A, PEG3, UHRF1, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, CCNH, CCNC, IKZF1, TNFSF11, HNF1B, SFRP2, EGR1, EGR2, EGR3, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3D, HNF4A, CD38, IL10, IL18, RGMA, IL1A, IL1B, YAP1, SATB2, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, EOMES, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, ETV1, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, TBX21, EGF, MAPK14, CD4, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAX5, PAX2, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, EPCAM, NR1H2, NR1H4, GTF2H1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, DAB2, COPS5, MAFB, MAFF, BCL3, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR4, TLR2, SP100, CDX2, CDX1, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, KLF13, CKAP2, DCN, DNM2, LEF1, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0051482;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;292.0931097099921;6.139487467954083;0.009776093515261451;0.7620939872166814;[CALCA, EDN1, GPR35, F2R, GNA15, C3AR1, AGTR1, GPR18, GPR157, F2RL3]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[FCN1, ORM1, LRRK2, PTPN22, TNF, PYCARD, IFIH1, CLEC5A, FFAR2, CD34, HAVCR2, IL10, POSTN, CHUK, SYK, DDX58, RIPK2, F2R, MIF, IL17RB, MMP12, TLR1, FGR, IL1A, IL1B, IGHD, TLR8, CLEC4E, TLR4, TLR2, CD274, CSF1R, TWIST1, GATA3, NOD2, PRKCZ, RASGRP1, NLRP3, CD58, CCL19, CD14, IL33, FZD5, CRTAM, MAPK14, CD2, NLRP12, CD244, IL17A]
GO:0034504;protein localization to nucleus;6.0;0.7192862368539868;0.682763431017138;8.763526815005518;32.77360880529348;4.8942717050940985;0.001096903192380182;0.5734135951955668;[NUP107, CSE1L, HHEX, XPO1, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, PLK1, RANBP6, PML, COL1A1, PIKFYVE, NUP35, RAN]
GO:0070208;protein heterotrimerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;7.212124270218933;0.002859955186148837;0.7197477358342742;[COL1A1, COL1A2, COL6A2, NUP62, COL6A1, NUP54]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, KIF4A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0070447;positive regulation of oligodendrocyte progenitor proliferation;9.0;1.0;0.896240625180289;9.628524252492122;486.0421787932986;8.67846133901236;0.016267394314649825;0.8400575416471059;[LYN, LRP2]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, JAK3, DUSP1, RIPK2, GMIP, SIRT1, DUSP6, PTAFR, STAT4, DMD, PKN1, LGR4, CTGF, SESN3, KCNH1, KCNH2, CISH, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, G3BP2, TNFRSF10B, BMX, CORO2A, NFKB1, NFKB2, LRRK2, PIK3CD, TNFRSF1B, SPTB, LCP2, LCP1, DTL, BIRC2, BIRC3, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, TRIB1, RIN2, EPHA2, PIK3R5, RACGAP1, CD14, PAG1, CCR1, PTK2, CALM3, RGL4, CD24, RGL1, CD40, CETN3, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR2, IL18, GAB2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK2, DOK3, TYROBP, CARD11, CALCA, PSEN2, RASGRP1, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, GNAQ, PLEK, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, EPS8L1, EPS8L3, EGF, MAPK14, MAPK13, TEK, CYFIP1, EPS8, STMN1, CYP1B1, MED1, PRKCH, DAPK1, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, PRKCZ, PLCG2, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, BTG2, ADM, IFIH1, NFAM1, PAX2, CIT, HCLS1, PLCB1, HBEGF, EXOC1, GSN, CCL20, CARD9, POU4F1, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, RAB31, CSF1R, CALCRL, CUL5, ITPR3, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK1, BCL2, CSPG4, LAT, BCL2L1, PIK3C2A, TREM1, TLK1, CHUK, TFDP1, IL3RA, CX3CR1, CEBPB, NLRC3, NOD2, RAB21, PLN, PML, DNAJA3, CALML4, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, STRADB, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, GUCY2C, SP100, PTGER2, CXCR5, CXCR4, CXCR6, AIF1, CXCR1, CXCR3, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, CSF2RA, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, ZAP70, CAMK2D, NCAM1, TSHR, PIKFYVE]
GO:2000010;positive regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;7.004484905440688;0.002466909593039506;0.7091290490632969;[FCER1G, TNF, AKT1, CD247]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[GREM1, SFRP4, SYK, EGF, FMR1, NTF3, PLCG2, ARRB1, ARRB2, SELE]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, RIN2, IQGAP3, RASGRP1, RASGRP4, G3BP2, HMOX1, JUN, HACE1, PLK2, DHCR24, ARHGAP30, COL1A2, BCL6, RGL4, RGL1, LAT, DOCK5, CDKN1A, DOCK4, ARHGAP6, ARHGAP4, RAC2, RALGPS2, ARHGEF12, CHUK, RHOG, RHOH, VAV1, RAB33B, CCNA2, RHOU, AIF1, RAB21, PAK1, PDPN, EPS8L1, EPS8L3, DNAJA3]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, PRF1, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, KCTD12, KCTD15, BLM, MGST1, ITPR3, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, DPYS, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, RXRA, GCH1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:1902961;positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;11.0;1.0;0.9324289523296623;9.628524252492122;1348.57412674769;7.9853141584524145;0.04513556238432715;0.8407982897480031;[LYN]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, ETS1, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, HDAC2, PCNA, KCNA5, FOXO1, CST3, PDGFD, HMOX1, ECT2, JUN, KLF4, MAPK13, COL1A1, FABP1, IL6, NR4A3, FKBP1B, CDK1, BCL2, SDC1, EZH2]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, CDCA5, RAD21, HMOX1, SFN, BARD1, LYN, MCTS1, PLK2, PLK1, CDKN1A, BTG2, CHAF1B, CHAF1A, CTLA4, ACTL6A, SIRT1, UNG, USP1, PMS1, GTF2H1, FMR1, TNF, PYCARD, RUVBL2, RUVBL1, MACROD2, MEN1, MSH6, MSH2, BLM, CUL5, FOXO1, MAP2K6, FANCI, FANCG, COPS5, BCL6, CNOT3, BCL3, CDK1, BCL2, BCL2L1, MCM7, EXO1, TLK1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, TFDP1, DTL, PPP1R15A, UHRF1, CDC45, RBBP8, POLR2E, E2F1, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, DONSON, PML, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK1, TRIM25, SOX4, ESCO2, MIF, EPHA2, POLA1, TOP2A, FEN1, SUV39H1, BRCA1, BRCA2, PARP9, RAD51C, SGK1, YAP1, SP100, PCNA, RAD54B, RAD54L, GINS2, RPA1, MLH1, RPA3, NEDD4, TRIP13, DCLRE1A, LIG1, FANCD2, PSMD14, CCNB1, HMGA1, ISG15, JMY, TOPBP1, H2AFX, IRF7, BCL2A1, TAF9, POLD3, POLD1, MAPK14, POLE2]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP1, NRP1, NRP2, NCF1, NCF2, ITGB3, NCF4, CYBB, VAV1, SH2D2A, NCKAP1L, FYN, MAPK14, SULF1, PTK2]
GO:0001798;positive regulation of type IIa hypersensitivity;12.0;0.9326813400603323;0.9144609826203107;9.606051396640064;1378.0251110012991;9.083926447120524;0.04612126032313042;0.9126727335416687;[C3, FCER1G]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP107, CSE1L, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, RANBP6, PML, NUP35, RAN]
GO:0045780;positive regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;82.90338698468558;6.943860283624253;0.002774701754173115;0.7060287030842711;[TFRC, SYK, CA2, SPP1, TNFSF11, ADAM8, TNFRSF11A, TMEM64]
GO:0032959;inositol trisphosphate biosynthetic process;8.0;1.0;0.875;9.628524252492122;361.00324016623335;9.083926447120524;0.012082453566540795;0.839552420951524;[PTAFR, PLCG2]
GO:0071364;cellular response to epidermal growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.088194173566533;0.003262744749111514;0.63447084575632;[MCM7, AKT1, PLCG1, MED1, CAD, PAX2, COL1A1, VIL1, ID1, SNAI2]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[EPHB2, EPHB1, AP2M1, MMP2, MMP9, EPHA3, EPHA2, SDC2, PAK1, FYN, LYN, PTK2]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[SERPINE1, EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, PRKCD, IL23A, BTK, AGTR1, SERPING1, CFB, CFH, CFI, GATA3, ADAMTS12, CFP, PLA2G7, C2, C3, C7, CD19, S100A12, A2M, ELANE, LYN, BST1, CD28, FFAR2, CCR7, CCR2, IL10, ANXA1, FCER1G, IL18, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, C1QB, C1QA, PTGS2, NT5E, IGKC, CCL18, IL33, CCL23, NR1H4, OSM, NLRP12, ZYX, IL17A, C1QC, PROS1, RORA, TNF, CLU, ETS1, CDH5, IGHG1, GHSR, ADCYAP1, FANCD2, ADAM8, S100A9, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CR2, CR1, TNFRSF1B, LTA, XCL1, BIRC2, BIRC3, C1S, C1R, NLRC3, NOD2, CNR1, CCL5, CCL4, SNCA, MAPK14, KLF4, MAPK13, CD6, TEK, FCGR2B]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[ACHE, CALCRL, LRP1, TFRC, ITGB2, ADM, ARRB1, ARRB2, CXCR1, CXCR2, CD36, AP2M1, SNCA, FCER1G, SYK, CAV1, LILRB1, DNM2, CEACAM1, RAB31, NEDD4, CD9, RAMP1]
GO:0010543;regulation of platelet activation;8.0;0.7866048967936545;0.7683024483968273;9.510741216835738;81.8829764000265;6.343086423195323;0.0027405495302144796;0.6993857346658935;[LYN, PDGFRA, FCER1G, SYK, TXK, PRKCD, PLEK, PDGFA, ALOX12, SELP, THBD, CEACAM1, PDPN, CD9, PRKCQ, TLR4]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[ABCA1, FCER1G, SYK, ITGB2, CD9, CD36]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CSF3, CD80, PIK3CD, ARRB2, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, IGFBP5, GAB1, IL18, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, HCLS1, ADAM8, HBEGF, ENG, PDGFA, GATA3, THBS1, PIK3R5, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[, IL1RN, TNF, PROK2, TNFSF11, PDGFRB, MAP2K2, F2R, MIF, ADAM9, ADAM8, C5AR1, FPR1, TGFA, PDGFA, TNFRSF11A, IQGAP3, RASGRP1, PIK3R5, PDGFD, PDGFC, S100A12, ELANE, DRD4, MAP2K6, TGFB1, FZD5, FZD8, EIF2AK2, GH1, BMP2, CDK1, NOX4, CSPG4, CD24, EZH2, CD40, LRRK2, ARRB1, GHR, MAP4K1, EDN1, SYK, RIPK2, DUSP6, MDFIC, IL1B, KIT, PDE5A, TLR6, TLR4, CXCR4, NOD2, THBS1, PAK1, NTF3, CSK, CCL19, CD74, EGF, MAPK14, CD40LG, PKN1]
GO:0035023;regulation of Rho protein signal transduction;9.0;0.8436909121759173;0.8180860812682478;9.318369324188282;48.758993290020136;4.879233827729558;0.0016319196251719597;0.645764870037956;[NRP1, ARHGEF10L, ARRB1, EPS8, ARHGDIA, STMN1, ARHGDIB, PDGFRB, PLEKHG1, ARHGEF12, GPR35, F2R, ARAP3, VAV1, TIAM2, FGD3, FGD4, EPS8L1, EPS8L3, ECT2, ABCA1, COL3A1, BCL6, DLC1, GPR18, F2RL3]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[PTPN22, DUSP10, PPP2R1A, NUP62, DUSP2, DUSP3, DUSP1, PAQR3, PRKCD, IRAK3, DUSP6, SFRP2, IL1B, LYN, CAV1, PTPN6]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, GAB2, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG2, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0038094;Fc-gamma receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.857092701852345;0.002626513627734276;0.6233919466506386;[CYFIP1, CD3G, IGHG1, FCGR3A, FCGRT, FCER1G, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, CLEC4D, CLEC4E, PAK1, IGKC, IGLV1-44, PLCG2, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP1, CD3G, IGHG1, FCGR3A, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, PLCG2, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0006661;phosphatidylinositol biosynthetic process;8.0;0.7508913569872202;0.7504456784936101;9.237657943805111;661.808482261977;4.917261223318797;0.022150134312343243;0.6264689676365554;[PIK3CD, PIK3C2A, FGF5, GAB1, PIK3R3, INPP5D, PLCG2, PIP5K1B, BMX, PIKFYVE]
GO:0046638;positive regulation of alpha-beta T cell differentiation;10.0;0.7671156992804218;0.7987988615011312;9.488762310116963;1285.3660192826185;5.970411137910149;0.04302004391107474;0.7205681151061569;[CD86, CD83, CD80, IHH, PRKCZ, HLX, MYB, NLRP3, NCKAP1L, CCL19, IL12RB1, ANXA1, SYK, RIPK2, IL18, ZAP70, IFNG, IL23A, RARA]
GO:0045425;positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[SYK, CD80]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CLEC10A, ICAM2, ICAM3, PAK1, KLRK1, PLCG2, MUC13, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, PRKCD, NFKB1, MUC3B, CLEC4A, CLEC4D, CLEC4E, CARD11]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, SPARC, PROS1, ITGB3, ITGA2B, SERPINE1, PLEK, F13A1, CTSW, CLU, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, APLP2, ANXA5, ACTN4, F5, MMRN1, PECAM1, SERPING1, TLN1, VCL, CFD, STXBP2, PDGFA, THBS1, PSAP, FLNA, A2M, LYN, TGFB2, TGFB1, EGF, PCDH7, FN1, LHFPL2, PPBP, SELP, TF, CD9, PF4]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[TREM2, CD3E, TNF, JPH2, CCL4, SYK, TRAT1, ZAP70, P2RX5, CD4, CALM3]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, PLEK, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, TYROBP, ADAM9, ITGA7, TLN1, CDH17, TXK, THY1, PTK2, COL3A1, ZYX, PLP1, LAT]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[LYN, IL10, TNFRSF13B, PAWR, INPP5D, BTK, CTLA4, MNDA, PKN1, FCGR2B]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, HDAC2, PTGS2, THBS1, HMOX1, LYN, HSPA6, MYOF, EIF2S1, CXCL10, IL1A, TFEC]
GO:0046641;positive regulation of alpha-beta T cell proliferation;10.0;0.8653626801206646;0.8479223519212526;9.54628615425515;937.8544877713971;6.8867018697843045;0.03138914569146771;0.7674272657460779;[BLM, SYK, RIPK2, IL18, CD3E, HLA-E, ZAP70, IL23A, CD28, XCL1, CCR2]
GO:0060828;regulation of canonical Wnt signaling pathway;7.0;0.6954798709641801;0.6986593007392905;8.83001655627435;44.04846258837617;4.37439624580819;0.0014742624017903352;0.5746261926980603;[RUVBL2, RUVBL1, SOX7, SOX4, WLS, TLE4, SFRP4, SFRP2, DAAM2, NAIP, FOXO1, FZD1, EGR1, JUP, FZD5, CAV1, NFKB1, COL1A1, BMP2, DAB2, GNAQ, SNAI2, CDK14, LRRK2, AXIN2, AES, GREM1, ASPM, PFDN5, YAP1, LEF1, FRZB, CTHRC1, EGF, TMEM64, MAPK14, PPP1CA, SULF2, LGR4]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, RIPK2, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, IL10RA, HLA-DPB1, PF4, CSF3, CSF3R, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC2, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RB, PTPN6, IL1RN, IFI30, IFIT1, IFIT3, IFIT2, ICAM1, TNFSF11, TRIM25, RSAD2, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IFI27, IL23A, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, IL10, SYK, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, IRF8, LTB, CAMK2D, SAMHD1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[TNC, IHH, FHL2, CYR61, FBL, AKT1, JUNB, MEF2C, TPM4, IGFBP5, IGFBP3, RUNX2, VCAN, COL6A1, EPHA2, LEF1, HSD17B4, TWIST1, GPNMB, FIGNL1, SPP1, HSPE1, COL1A1, BMP2, PSMC2, ALPL, SNAI2, RBMX, LGR4]
GO:0001805;positive regulation of type III hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1205.6585476054483;9.083926447120524;0.04035230656610712;0.8969813732811862;[FCER1G, BTK]
GO:0033630;positive regulation of cell adhesion mediated by integrin;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.61675044652454;6.943860283624253;0.0011585914843924019;0.6453503496879909;[TGFB2, SFRP2, SYK, CCL21, CCL5, ADAM9, NCKAP1L, PTPN6, CXCL13]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, PIK3CD, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, RIPK2, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, TXK, GATA3, THY1, PAK1, INPP5D, PLCG2, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, BTNL8, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, LAT, HLA-DRB1]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, TXK, PIK3CD, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, PLCG2, CTLA4, CD38, NCKAP1L, IGHA1, LYN, MEF2C, SYK, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, BCL2, PTPN6, MNDA]
GO:2000670;positive regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.63842847306384;8.67846133901236;0.004305412433924055;0.8400575416471059;[LYN]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD5, CD28, PTPN6, CD24, CARD11]
GO:0060252;positive regulation of glial cell proliferation;9.0;0.8933024483968273;0.8428918493787028;9.587702257971866;465.4406966640378;7.292166977892469;0.015577881247913653;0.769162383550154;[LYN, PRKCH, MYB, LTA]
GO:0044344;cellular response to fibroblast growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.444869117505266;0.003262744749111514;0.6527112189764278;[POSTN, EGR3, COL1A1, NR4A1, CCL5, CCL2, SNCA]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, TXK, SLA, SLA2, GRAP2, FYN, CSK, JAK3, LYN, SYK, MATK, BMX, PTK2, FGR, ZAP70, HCK, LCK, FES, BTK]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[LYN, MEF2C, TNFRSF13B, TNFAIP3, TNFSF13B, BCL2, NCKAP1L, PKN1]
GO:0021884;forebrain neuron development;6.0;0.8436909121759173;0.7449657686781032;9.223059144383958;35.3312604386653;6.8867018697843045;0.0011825054908121085;0.6753065664753021;[ROBO2, UQCRQ, GNAQ]
GO:0045954;positive regulation of natural killer cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.526741558182179;431.31665099041965;6.444869117505266;0.014435780148864921;0.7258315315665724;[LAG3, SH2D1A, CRTAM, RASGRP1, VAV1, IL18RAP, KLRK1]
GO:0050861;positive regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;365.0896954818653;7.8311634786251565;0.01221922354838398;0.7754860644832351;[LYN, PRKCH, NFAM1, STAP1]
GO:0051279;regulation of release of sequestered calcium ion into cytosol;9.0;0.7369933605727446;0.7647373054666613;9.242861771680136;148.50473241193134;5.486614186532078;0.004970319748245178;0.676826329833192;[CXCL9, CAMK2D, THY1, CORO1A, SLC8A1, JPH2, PLN, CD19, DMD, PLCG1, SNCA, LYN, TGFB1, TRPC1, PRKCE, F2R, CXCL10, CXCL11, FKBP1B, XCL1, PTPN6, CALM3, F2RL3]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:1902618;cellular response to fluoride;5.0;1.0;0.7902410118609202;9.628524252492122;70.21110216540774;9.777073627680469;0.0023499024035866234;0.7902410118609202;[COL1A1]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, YAP1, HDAC2, TNC, KLF4, PHB2, PAX2, AQP1, COL1A1, MYB, RARA, HOXA2, EPHA3]
GO:0001812;positive regulation of type I hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1109.5695898802176;9.083926447120524;0.0371362956254912;0.8969813732811862;[FCER1G, BTK]
GO:0002902;regulation of B cell apoptotic process;9.0;0.7369933605727446;0.7647373054666613;9.117698628726131;22.875998380894767;6.8867018697843045;7.656390787466303E-4;0.7484268790654467;[LYN, IL10, CD74, MIF, AURKB, BCL6, BTK]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[CD74, FCER1G, PRKCD, EXO1, INPP5D, BCL3, IRF7, TLR8, CD27, FCGR2B, IL13RA2, HLA-DQB1]
GO:0010803;regulation of tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;58.00234281560482;5.734022359845919;0.001941286215318787;0.64415753539903;[TNFAIP3, TNF, PYCARD, CHUK, SYK, NR1H4, TRAF1, BIRC2, BIRC3]
GO:0031960;response to corticosteroid;6.0;0.7140352122741334;0.6801379187272112;9.05316010758856;61.63829009254609;4.689477292448085;0.0020629780985379075;0.5629403994089356;[CDKN1A, IL1RN, SPARC, ADM, TNF, CTGF, AQP1, ICAM1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, CYBB, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, ENG, PCNA, FECH, ABCB4, PTAFR, PTGS2, TYMS, AIF1, FOXO1, IGFBP7, TGFB1, COL1A1, IL6, BCL2, ALPL, SDC1, FOSB]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, IL1RN, CSF3R, C5AR1, ITGB2, PIK3CD, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL2, XCL1, S100A9, S100A8, PF4]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, ICAM1, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, SIRPA, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, DOK2, PRTN3, ADAM8, S100A9, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, ESAM, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, PIK3CD, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, SLC7A9, IL1B, CEACAM5, KIT, PECAM1, XCL2, XCL1, CD48, CEACAM8, CX3CR1, CCL13, SELPLG, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR3, TBX21, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, CSF3, SPARC, CD80, GFI1, SERPINE1, CXCL13, MPO, LOXL1, ICAM1, PYCARD, EDNRB, JUNB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, TRIB1, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, PLCG2, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, NFKB2, SELP, CXCL10, CXCL11, IL6, ALPL, CD27, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, ADM, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, RARA, IRF8, TLR4, CX3CR1, CEBPB, HDAC2, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, IL10RA, NR1H4, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:0030199;collagen fibril organization;5.0;1.0;0.7902410118609202;9.628524252492122;53.964823970696955;5.9928839937622085;0.0018061540931107725;0.5967173779995258;[TGFB2, COL14A1, LUM, COL11A1, COL12A1, LOXL2, COL1A1, GREM1, COL3A1, SFRP2, COL1A2, COL5A1, LOX, COL5A2, CYP1B1]
GO:0071306;cellular response to vitamin E;8.0;1.0;0.875;9.628524252492122;314.0784094220964;9.083926447120524;0.010511921711140423;0.839552420951524;[COL1A1]
GO:0043306;positive regulation of mast cell degranulation;11.0;0.8933024483968273;0.8790801765280758;9.584072489921288;1034.300036297698;7.212124270218933;0.03461709140528456;0.8012573229067359;[FGR, FCER1G, SYK, GAB2]
GO:0038110;interleukin-2-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[SYK, IL2RB, IL2RG, JAK3]
GO:0002281;macrophage activation involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;81.79914540449643;7.379178354882098;0.0027377437822370863;0.7004918368257019;[CX3CR1, IL33, SUCNR1, TYROBP, SYK, PRKCE, HAVCR2]
GO:0002283;neutrophil activation involved in immune response;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;82.20461051260416;3.594988720963838;0.002751314334510546;0.5347672556313635;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, SYK, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, GGH, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0007213;G-protein coupled acetylcholine receptor signaling pathway;7.0;0.7980440201809971;0.7499413753476991;9.260799472366804;50.14720301582843;6.8867018697843045;0.001678381755387122;0.7031056191423581;[CHRM2, GNA15, CHRM1, GNAQ, HRH4, PLCB1, GNAI2]
GO:0023014;signal transduction by protein phosphorylation;8.0;0.7248374789738407;0.7374187394869203;9.153100555777048;203.92357026499027;3.9689311377000256;0.006825138377471068;0.5779713229561524;[, IL5RA, TNF, FGF5, TNFSF11, KCNH1, MEN1, PDGFRB, MEF2A, KCNH2, PDGFRA, MED1, MEF2C, MAP2K2, PAQR3, EREG, BTC, TRIB1, PDGFA, CSF2RB, IQGAP3, CSF2RA, RASGRP1, RASGRP4, SPTA1, MAP2K6, LYN, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, JAK3, MAP4K1, CHUK, RIPK2, STRADB, IL18, GFRA3, SPTB, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, PAK1, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, MAPK13, KITLG, IL2RB, TEK]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[F11R, ICAM1, TIAM2, DEPDC1B, RIN2, LLGL2, EPHA2, THY1, RACGAP1, NCKAP1L, A2M, JUN, EZH2, ARHGAP9, DENND1B, NRP1, CD40, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, DEPDC1, PLCB1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, DLC1, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP19, ARHGAP15, RASGRP1, ADAP2, ECT2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, GNAQ, ARHGAP11A, DOCK4, LRRK2, ARRB1, TAGAP, ARHGEF12, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL2, XCL1, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0043304;regulation of mast cell degranulation;10.0;0.7980440201809971;0.8142630219514189;9.523163736834295;224.79395709788088;6.409777797693995;0.007523651442639206;0.7430373465201421;[LYN, FCER1G, SYK, STXBP2, GAB2, FGR, FES, RAC2, HMOX1, IL13RA2]
GO:0007215;glutamate receptor signaling pathway;6.0;0.7980440201809971;0.722142322680643;9.089527751759436;26.50247477320489;5.9928839937622085;8.87013979980389E-4;0.6295966787287501;[FMR1, GRIK3, GRM5, GNAQ, HOMER3, PLCB1, GRIA4]
GO:0002554;serotonin secretion by platelet;10.0;1.0;0.9152410118609203;9.628524252492122;131.6544252072528;8.67846133901236;0.0044063551303965215;0.8590579283277371;[FCER1G, SYK, P2RX1]
GO:0007207;phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;80.58987167142863;7.9853141584524145;0.00269727047866701;0.7833693374183408;[CHRM2, GNA15, CHRM1]
GO:0007603;phototransduction, visible light;7.0;1.0;0.8509193652572005;9.628524252492122;130.00043273990028;7.57984905034425;0.0043509974910108115;0.738553198190834;[GNAQ]
GO:0032928;regulation of superoxide anion generation;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;29.554879433861746;6.781341354126479;9.891752169867288E-4;0.6977174774718518;[TGFB1, ITGAM, SYK, PRKCD, ITGB2, FPR2, GNAI2, CD177]
GO:0002316;follicular B cell differentiation;9.0;1.0;0.896240625180289;9.628524252492122;149.8071031872776;9.083926447120524;0.005013908926038414;0.8607930461318132;[PLCG2, FCGR2B]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[CELSR1, CDH3, AP2M1, SOX4, WLS, TLE4, RNF43, SFRP4, HOXB9, SFRP2, CCNE1, DAAM2, PFN1, TCF7, GATA3, APCDD1, PLCG2, FZD1, FZD5, FZD8, NR4A2, VANGL1, DAB2, SDC1, SNAI2, CD24, CDK14, LRRK2, TGFB1I1, ARRB2, HHEX, AXIN2, AES, PLCB1, LEF1, FRZB, CTHRC1, EGF, TMEM64, KLF4, LGR4]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, ADCYAP1, MAP1B, S100A9, EPHA3, LYN, FZD1, SYT2, FN1, CXCL12, FES, PLXNB2, EZH2, ROBO2, NRP1, NME1, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, FKBP1B, CAMK1]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, CLU, PYCARD, IFIH1, CD36, CCR2, HAVCR2, FCER1G, DDX58, RIPK2, CYBB, MIF, HLA-E, TLR1, IL23A, TLR4, TLR2, HDAC2, PTAFR, LY96, TWIST1, NOD2, THBS1, RASGRP1, CCL19, CD14, FZD5, CARD9, AZU1, CD2, PF4]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[CCL21, PRKCE, F2R, FASLG, ITPR3, JPH2, PTPRC, LCK, FKBP1B, PLCG2, XCL1, CCR7, CCL19, CCR5]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, CETN3, CALML4, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR2, EDN1, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CAMK2D, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR3, CXCR2, PLCG2, DMD, PLCG1, CCR10, CCR1, VCAM1, CCL20, AZU1, SELE, SELP, FKBP1B, CALM3, LAT]
GO:0032765;positive regulation of mast cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;8.67846133901236;0.010436510936514811;0.8400575416471059;[FCER1G, NR4A3]
GO:0060397;JAK-STAT cascade involved in growth hormone signaling pathway;8.0;1.0;0.875;9.628524252492122;26.42836680105094;7.212124270218933;8.845336528452411E-4;0.7438283705770736;[LYN, GHR, GH1, PRL, JAK3]
GO:0090025;regulation of monocyte chemotaxis;9.0;0.8933024483968273;0.8428918493787028;9.510741216835738;137.5287080193099;6.641579411751319;0.004602962089604771;0.7358913051622797;[LYN, CCR1, SERPINE1, FPR2, PLA2G7, AIF1, GREM1, CXCL10, CXCL12, CCL5, CCL1, S100A14, CCR2]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRA, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, PIK3R5, C3, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, GNG11, MARCO, PNOC, CALM3, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, ADM, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, EDN1, GPR37, ANXA1, GPR35, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, PLCB1, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR3, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, FCN1, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, CISH, SPNS3, APLP2, F2R, NPY1R, DGKZ, PDGFRL, ADCYAP1, SPNS1, OR2C3, GNAZ, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, ITPR3, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, GNAQ, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, PLEK, CXCL1, ARRB1, ARRB2, CXCL3, CXCL2, CXCL5, LTB4R, GRM5, CA2, PDE4B, PTGIR, ARHGEF12, GLP2R, OR2H1, XCL2, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, GNA15, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0034144;negative regulation of toll-like receptor 4 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.697632086000634;0.011871713162238609;0.7898978880348613;[LYN, TNFAIP3, LILRA2]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[HMGB2, PTPN22, IFIH1, DHX58, CHUK, SYK, DDX58, RIPK2, MMP12, IRF7, TLR8, TLR7, TLR4, TLR2, HSPD1, PLCG2, CD14, NFKB1, NFKB2, MYD88]
GO:0002292;T cell differentiation involved in immune response;7.0;0.7586651285174919;0.7302519295159464;9.260799472366804;150.83672260445746;6.686031174322154;0.00504836936133411;0.692843310444282;[EOMES, SEMA4A, FCER1G, LEF1, RORA, GATA3, CLEC4D, BCL3, CLEC4E, IL18R1]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[YAP1, LRRK2, RUVBL1, SOX4, WLS, JUP, EGF, CAV1, AXIN2, NFKB1, SULF2, COL1A1, SFRP4, ASPM, SFRP2, DAAM2, LGR4, NAIP]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[LYN, PDGFRB, PDGFRA, TGFB1, CCL21, FPR2, NOD2, PTK2, FGR, KIT, CCR7, TEK, CCL19]
GO:0043551;regulation of phosphatidylinositol 3-kinase activity;10.0;0.8259837884571596;0.8282329060895002;9.517298617381897;113.71851024663684;5.9928839937622085;0.0038060561979401893;0.7217173779995258;[LYN, PDGFRB, PDGFRA, TGFB1, CCL21, PIK3R3, FPR2, NOD2, KLF4, PTK2, PIK3R5, FGR, KIT, CCR7, TEK, CCL19]
GO:0007188;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;7.0;0.7090535922965819;0.7054461614054914;8.712233520617966;27.67007993335845;4.535326612620827;9.260926739143067E-4;0.5828561791408859;[CHRM2, CHRM1, GRIK3, ADM, LTB4R, AKAP12, GRM5, EDNRA, RGS1, PRKACB, PTGDR, LHCGR, PTGIR, EDN1, GPR37, GLP2R, NPY1R, MC3R, ADCYAP1, ADCY9, GNAZ, CALCA, CALCRL, PTGER2, FPR1, FPR2, GPR84, ADRB2, GNAI1, GNAI2, GNA15, PLN, CNR1, HRH4, PSAP, FLNA, S1PR3, DRD4, ABCA1, GABBR1, HTR1E, TSHR, MARCO, GNAQ, RAMP1, LGR4]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, GGH, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0038063;collagen-activated tyrosine kinase receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;57.50475921673876;7.474488534686424;0.0019246325400609058;0.7572456912631272;[COL1A1, SYK, COL4A2, COL4A1]
GO:0007189;adenylate cyclase-activating G-protein coupled receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.249034630787218;56.871035456649615;5.192106149009898;0.0019034223761250782;0.6617651750982834;[CALCA, CALCRL, PTGER2, ADM, ADRB2, GNAI2, PLN, PTGDR, ABCA1, LHCGR, PTGIR, TSHR, MC3R, ADCYAP1, ADCY9, GNAQ, RAMP1, LGR4]
GO:0060158;phospholipase C-activating dopamine receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;57.13191933594548;7.138016298065211;0.0019121539247848626;0.7159578506919597;[GNA15, GNAQ]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[CYFIP1, SPARC, CTGF, ICAM1, EDNRB, SESN3, AKT1, PRKACB, MEN1, GHSR, LHCGR, IGFBP5, PRKCD, CYBB, EREG, POR, ADCY9, RAB31, PRKAR1B, ABCB4, SLC30A10, FOXO1, PRKAR2B, CYC1, LYN, EGR1, EGR2, EIF2B3, TGFB1, CAV1, GGH, CDC6, NFKB1, NR4A2, COL1A1, NR4A1, CXCL12, NR4A3, FBN1, BTG2, ADM, HHEX, TIMP1, IL10, EDN1, ANXA1, ARG1, GLP2R, CAD, SIRT1, TGFBR3, CCNA2, CEACAM1, IL1B, TLR2, RETN, PTGS2, GNAI1, PAK1, PLN, FYN, CSK, SORT1, SORBS1, TSHR, TEK]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, MPO, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, HLA-E, CLEC4D, SLPI, IL23A, CLEC4E, S100A9, S100A8, SEH1L, C5AR1, CFP, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, ISG15, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, BCL3, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, GNLY, STAB1, CTSG, CD36, CAMP, HAVCR2, IL10, FCER1G, SYK, ANXA3, RIPK2, TLR1, FGR, IGHD, LTA, IRF8, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPB, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, NR1H4, CD4]
GO:0043313;regulation of neutrophil degranulation;10.0;0.8933024483968273;0.861892236059334;9.537552474286395;150.84516981286367;7.8311634786251565;0.005048652081797471;0.8157270763441555;[ITGAM, SYK, PTAFR, ITGB2, CD177]
GO:0045579;positive regulation of B cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.503361109538115;803.2041625246294;7.212124270218933;0.026882520482883615;0.7650689957573628;[SYK, INPP5D, BTK, ATP11C, CD27, NCKAP1L]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[ITK, PIK3CD, CD3G, PTPN22, RORA, CD3E, CD3D, CCR9, CCR6, SOX4, EOMES, ANXA1, FCER1G, RSAD2, RHOH, RUNX2, VAV1, ZAP70, CLEC4D, LCK, CD8A, KIT, CLEC4E, BLM, TXK, LEF1, TCF7, GATA3, TBX21, NKX2-3, EGR1, SEMA4A, TGFB1, BCL11B, FZD5, FZD8, BMX, CD4, PTPRC, MAFB, DNAJA3, BCL3, CD28, BCL2, IL7R, GPR18, IL18R1]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[CX3CR1, HDAC2, EPB41L5, PDGFD, FYN, MEF2C, EDN1, POSTN, TGFB1, ARG1, CAV1, COL1A1, COL4A2, NOX4, XCL1, FBN1]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[EHMT2, TNC, ICAM1, SESN3, LAMP2, SKP2, POSTN, CYBB, SFRP2, RRAGD, SIK1, ATF3, SEH1L, ABCB4, FOXO1, HMOX1, GAS2L1, LYN, JUN, EIF2AK2, EIF2S1, NR4A2, COL1A1, BCL2, CDKN1A, PLEKHF1, LRRK2, KRT20, ASGR1, UPP1, AVPR1A, FOS, SIRT1, AES, PTGS2, AIF1, FYN, NR1H4, SIPA1, FOXA3, FOXA2]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[ALAS2, SPI1, GATA3, IKZF1, GATA1, AHSP, JAK3, LYN, INHBA, KLF1, TGFBR3, TAL1, KIT, ACIN1, HCLS1, TRIM10]
GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;32.556158890958;6.409777797693995;0.0010896253394395913;0.618037346520142;[ITGB5, IFI30, CD36, FCGR1A, FCGR1B, FCER1G, CHUK, HLA-B, TAP1, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[, IL1RN, CCNH, CCNC, TCL1A, AKT1, PROK2, TNFSF11, PRKACB, ACSL1, SLC11A1, PRKCD, MIF, EREG, PRKAR1B, IL23A, FPR1, TGFA, PDGFA, IQGAP3, PRKCZ, PIK3R5, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, EGR1, ACE, FZD5, FZD8, EIF2AK2, CDC6, AZU1, PTK2, NOX4, CALM3, CD24, EZH2, CDKN1A, CD40, CCR7, MAP4K1, EDN1, SYK, RIPK2, STRADB, IL18, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD74, CCL21, CENPE, CD40LG, PKN1, CAMK1, CCNT2, NCF1, TNF, CLU, IL6R, PDGFRB, MAP2K2, F2R, ADCYAP1, ADAM9, ADAM8, CSF1R, CALCA, C5AR1, TNFRSF11A, ADRB2, RASGRP1, CCNB1, STAP1, ECT2, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, BMP2, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, ARRB1, CYR61, GHR, GRM5, GREM1, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, NOD2, THBS1, CCL5, FYN, CSK, SNCA, EGF, MAPK14, CD4]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, ETS1, CTGF, RUVBL2, CD38, PDGFRB, IL10, GHSR, POSTN, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, CST3, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, CD14, LYN, TGFB1, RIPK2, PRKCE, IL18, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0034136;negative regulation of toll-like receptor 2 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;8.390779266560578;0.011871713162238609;0.8253454670833372;[LYN, TNFAIP3, TLR6]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL1RN, TNF, PYCARD, IFIH1, CD36, IL6R, FCER1G, DDX58, RIPK2, F2R, EREG, TLR1, ADCYAP1, IL1A, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, NOD2, HSPD1, IL33, CARD9, LILRB2, MAPK13, IL6, MYD88, IL17A]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[SIRPG, TNF, SIRPB1, C2, PYCARD, C3, STAP1, CCL2, SIRPA, NCKAP1L, CD36, FCER1G, SLC11A1, AZU1, DNM2, IL1B, PTX3, FCGR2B]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCH, PRKCE, PRKCD, VRK1, PRKCQ, PRKCZ, CCNB1, PLK2, PLK1, CLK1, CDK1, BCL2, LRRK2, MAP4K1, CHUK, SYK, SGK1, CAMK2D, AURKB, MAPK14, MAPK13, CAMK4, PKN1, CAMK1]
GO:0016322;neuron remodeling;5.0;1.0;0.7902410118609202;9.628524252492122;39.55885145263549;7.474488534686424;0.0013239991574647927;0.6724867031240476;[GNAQ]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, F11R, TNF, CDH1, FCER1G, GOLPH3L, TTC7B, ATP1B1, ANK1, RAB31, PKP3, TSPAN33, PRKCZ, EPB41L3, FLNA, TSPAN5, JUP, KCNIP4, TSPAN15, EHD3, RAMP1]
GO:0050764;regulation of phagocytosis;7.0;0.6873818243518346;0.6946102774331178;9.05316010758856;47.10255867462412;5.4730085344763;0.0015764802492890249;0.6308092762312435;[SIRPG, TNF, SIRPB1, PYCARD, SIRPA, CD36, FCER1G, SYK, SLC11A1, DNM2, FGR, HCK, IL1B, PRTN3, TLR2, C2, C3, STAP1, CCL2, NCKAP1L, CSK, TGFB1, AZU1, PTX3, FCGR2B]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[SPARC, SERPINE1, MYLK, ICAM1, LGALS3, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, PFN1, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, SIRT1, F3, IL1A, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, AIF1, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, ETS1, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, ADAM8, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, VIL1, CXCL10, CXCL11, IL6, BMP2, DAB2, CXCL12, PTPRC, NR4A3, BCL2, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, PIK3CD, LAMC2, CXCL1, CXCL3, PIK3C2A, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL2, XCL1, LEF1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, SEMA4A, EGF, SEMA4B, LAMB1, MAPK14, SOD2, TEK]
GO:0032237;activation of store-operated calcium channel activity;12.0;1.0;0.9481203125901445;9.628524252492122;1441.322107930491;8.16763571524637;0.04823975384675163;0.8658135829017477;[PLCG2]
GO:0014003;oligodendrocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.09911675737102;6.558197802812269;0.001141266750656509;0.6256275524841266;[LYN, EIF2B3, TGFB1, GSN, CD9, WASF3]
GO:0090237;regulation of arachidonic acid secretion;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;83.13942816732954;7.9853141584524145;0.0027826018401329354;0.8046099625986299;[SYK, MIF]
GO:0008361;regulation of cell size;5.0;0.7763722522362496;0.6784271379790451;8.999915593069748;28.02071028012121;5.54296712308321;9.378279560736312E-4;0.5737086083097278;[PLEK, IQGAP3, AQP1, AKT1, SLC12A2, EDN1, SLC12A1, VAV1, XK, IL7R, SHANK3]
GO:0043200;response to amino acid;5.0;0.6441938053840475;0.612337914552944;8.412128928167629;56.712201515420396;5.104244793218563;0.0018981063470534028;0.5512723279577749;[TNF, CTGF, ICAM1, ALAD, SESN3, PDGFRA, EDN1, CHUK, ARG1, MMP2, CYBB, COL4A1, COL6A1, RRAGD, NAIP, CEBPB, PCNA, ABCB4, PDGFD, PDGFC, FYN, LYN, COL1A1, COL3A1, COL1A2, COL5A2, BCL2L1]
GO:0045588;positive regulation of gamma-delta T cell differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;1283.265958453736;8.67846133901236;0.04294975676506408;0.8590579283277371;[SYK, NCKAP1L]
GO:0051591;response to cAMP;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;79.54904468548885;5.192106149009898;0.0026624349361310785;0.5886448625081389;[SPARC, PTAFR, AQP9, SLC8A1, AQP1, THBD, JUNB, JUN, IGFBP5, DUSP1, FOS, NME1, COL1A1, KCNQ1, NDUFS4, NOX4, SDC1, MMP19, FOSB, TEK, SLC26A3, CFTR, BIRC2]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[ADARB1, PYCARD, PPP2R1A, AKT1, EPHB2, MEN1, CISH, PAQR3, PRKCD, TSC2, SFRP2, PRKAR1B, TRIB1, THY1, SOCS2, FLRT2, PRKAR2B, SFN, LYN, CAV1, PLK1, NR2F2, PTPRC, CDK6, GNAQ, PKIG, CDKN1A, LRRC4, TNFAIP3, PTPN22, HHEX, DUSP10, LRRTM4, NUP62, DUSP2, MYOCD, DUSP3, DUSP1, BGN, IRAK3, GP1BA, SIRT1, DUSP6, DCN, CEACAM1, IL1B, CEBPA, LRRC19, CDKN2C, PODN, PTPN6, PKN1]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[HDAC2, TGFB1I1, LEF1, TWIST1, LOXL2, EPB41L5, PDPN, TGFB2, TGFB1, AXIN2, COL1A1, BMP2, DAB2, IL1B, EZH2, ENG]
GO:0002774;Fc receptor mediated inhibitory signaling pathway;8.0;1.0;0.875;9.628524252492122;130.16139686502353;8.67846133901236;0.004356384815420379;0.8188169164668168;[LYN, LILRB1, LILRB2]
GO:0071230;cellular response to amino acid stimulus;6.0;0.7140352122741334;0.6801379187272112;8.962045319014338;283.89643900763554;5.6339389012889365;0.009501758323378283;0.6112402100070131;[CEBPB, ABCB4, TNF, SESN3, PDGFD, PDGFC, FYN, PDGFRA, MMP2, CYBB, COL1A1, COL3A1, COL1A2, COL4A1, COL5A2, COL6A1, RRAGD, BCL2L1]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, ADM, ICAM1, SESN3, AKT1, IL10, GHSR, CAD, SIRT1, CEACAM1, RAB31, TLR2, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, GGH, SORBS1]
GO:0097028;dendritic cell differentiation;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;22.452520143917486;6.343086423195323;7.514656432606705E-4;0.6146267465268138;[LYN, TGFB1, SPI1, TREM2, LILRB1, GATA1, CAMK4, PRTN3, CCR7, LTBR, CCL19]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, ZFAND6, RORA, BRCA1, ICAM1, PYCARD, TCL1A, AKT1, EDN1, POSTN, CHUK, SIRT1, XCL2, CHI3L1, XCL1, CCL13, CEBPA, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0050777;negative regulation of immune response;5.0;0.5193749703860713;0.549928497053956;7.293149336675085;78.83017544275083;4.909539177224887;0.0026383750295169523;0.5413150737011212;[IFNA2, TNFAIP3, ARRB2, TNF, LGALS3, DUSP10, DHX58, CTLA4, IL13RA2, JAK3, CCR2, HAVCR2, IL10, CD96, CR1, ANXA1, ARG1, SERPINB9, IRAK3, HLA-G, HLA-E, MMP12, ADCYAP1, CEACAM1, XCL1, SERPING1, CLEC12B, NLRC3, HLX, INPP5D, TBX21, HMOX1, A2M, LYN, IL33, TGFB2, TGFB1, NR1H2, LILRB1, COL3A1, PTPRC, BCL6, PTPN6, FCGR2B, IL7R]
GO:0070304;positive regulation of stress-activated protein kinase signaling cascade;8.0;0.7866048967936545;0.7683024483968273;9.394909401310617;268.25740884697916;4.746635706288034;0.008978334058114483;0.6177431707607042;[IL1RN, NCF1, TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, EDN1, SYK, RIPK2, MDFIC, IL1B, TLR6, PLCB1, TNFRSF11A, NOD2, RASGRP1, PAK1, CCL19, SLAMF1, LYN, TGFB2, FZD5, CCL21, CARD9, FZD8, EIF2AK2, BMP2, CD40LG, CD27, PKN1, LTBR, FCGR2B, NOX1]
GO:0070667;negative regulation of mast cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;83.65590509736859;9.777073627680469;0.0027998878581822827;0.8509193652572005;[LYN]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PRKACB, MED1, MEF2C, CXADR, PRKCH, PRKCE, PRKCD, SERPING1, PRKCQ, CFB, CFD, CFH, HHLA2, CFI, FPR1, FPR3, FPR2, GATA3, THY1, CFP, PRKCZ, C2, C3, KLRK1, C7, PLCG2, HMOX1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, COL1A2, HLA-DRB1, DENND1B, ITK, SIGLEC9, IFIH1, CTLA4, JAK3, HLA-DPA1, HAVCR2, ANXA1, DUSP3, ARG1, IFNGR1, RIPK2, FCRL3, NFAM1, IFNGR2, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, PLSCR1, RARA, TLR10, HLA-DQB1, PTAFR, UNG, HLA-DMB, CCL19, IL12RB1, NR1H2, CARD9, NR1H4, KIR3DL1, COL3A1, HLA-DPB1, PKN1, CLC, SIGLEC7, LGR4, PROS1, CXCL13, TNF, CLU, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, CLEC4A, ADCYAP1, CLEC4D, MSH2, ADAM8, CLEC4E, S100A9, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, BCL2, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, PIK3CD, TREM2, PTPN22, ARRB2, ITGAL, TREM1, TNFSF13B, FCGR3A, DUSP10, ITGB7, CR2, CR1, CHUK, ITGA4, PVRIG, LCK, XCL1, LCP2, BIRC2, BIRC3, C1S, UNC93B1, C1R, NLRC3, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1A, FCGR1B, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, GFI1, ICAM2, ICAM3, ICAM1, LGALS3, DHX58, ICOSLG, RSAD2, SLC11A1, HLA-B, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IL23A, BTK, TXK, STXBP2, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, CD14, A2M, PAG1, SH2D1A, TNFSF13, PILRA, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, CD40, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, MUC13, CD38, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, IL10, FCER1G, SYK, IL18, GAB2, PARP9, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, CD48, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA1, LILRA2, PAK1, IGKC, NPDC1, CD74, IL33, LILRB1, LILRB2, MLH1, CD40LG, C1QC, CD86, FCN1, CD80, TRAC, IL18RAP, IL6R, CD96, THEMIS, MUC3B, OSCAR, TYROBP, CD8B, CD8A, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, DDX60, KIR2DL3, RASGRP1, KIR2DL4, STAP1, NLRP3, LPXN, KLRC1, BTNL8, TGFB2, TGFB1, VCAM1, CAV1, CRTAM, NFKBIA, IL6, NR4A3, SELL, FES, KLRD1, IL7R, IGKV3-20, HMGB2, TNFAIP3, PDE4B, DDX58, MMP2, IRAK3, FGR, ZAP70, IFNG, LTA, IRF7, LTF, COLEC12, CLEC12B, SAMHD1, HSPD1, CNR1, HLX, TBX21, TRAT1, MAPK14, CD4]
GO:0070668;positive regulation of mast cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;83.5280859103553;9.777073627680469;0.002795609865022748;0.8509193652572005;[LYN]
GO:1900086;positive regulation of peptidyl-tyrosine autophosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;1786.9389585583017;8.16763571524637;0.05980723880229299;0.8501222226412654;[GREM1, ACE, SYK]
GO:0050707;regulation of cytokine secretion;8.0;0.5887823193610073;0.6693911596805037;8.358061706897352;114.42085987655861;4.647174912757396;0.003829563207980042;0.6126567411541474;[FCN1, TNF, PYCARD, CLEC5A, GHSR, POSTN, IL1R2, F2R, MIF, CLEC4E, CD274, CSF1R, TWIST1, GATA3, PRKCZ, RASGRP1, NLRP3, CD14, LYN, FZD5, CRTAM, FN1, ORM1, LRRK2, IFNA2, PTPN22, LRRC32, IFIH1, FFAR2, CCR7, CD34, HAVCR2, IL10, ANXA1, CHUK, SYK, DDX58, RIPK2, IL17RB, MMP12, TLR1, FGR, IL1A, BANK1, IL1B, IGHD, TLR8, TLR10, TLR6, TLR5, TLR4, TLR2, NOD2, CD58, CCL19, IL33, NR1H4, LILRB1, MAPK14, PML, CD2, NLRP12, FCGR2B, LGR4, CD244, IL17A]
GO:0009743;response to carbohydrate;4.0;0.6347111282356054;0.5673555641178027;8.102467948997072;27.321196622860832;4.720827822332161;9.144158634865458E-4;0.49142335437501145;[SPARC, SLC8A1, CTGF, ICAM1, LGALS1, HNF4A, SOX4, MEN1, RMI1, HNF1B, PAX2, NME1, IL1B, COL6A2, CALCRL, PTGS2, THBS1, CST3, MAP2K6, LYN, EGR1, CDT1, EIF2B3, TGFB1, MAPK13, LIN28A, FKBP1B, NOX4]
GO:0007202;activation of phospholipase C activity;9.0;1.0;0.896240625180289;9.628524252492122;83.73920694944017;6.444869117505266;0.0028026758962043192;0.7258315315665724;[ITK, TXK, C5AR1, AVPR1A, SELE, RASGRP4, EDNRA, GNA15, GNAQ, PLCG1]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB2, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, SH2D2A, TXK, TGFA, PDGFA, PIK3R3, SLC30A10, PRKCZ, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PILRA, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, GAB2, VAV1, HCK, KIT, PLCB1, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF1, SULF2, NCF1, NCF2, NCF4, SLA, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, MATK, TSC2, CYBB, PDGFRL, DOK2, COL4A2, CD8B, KIF16B, COL4A1, CD8A, BLK, CSF1R, CUL5, RASGRP4, FOXO1, SOCS2, STAP1, TGFB1, CAV2, CRIM1, BMX, VIL1, GH1, NR4A3, FES, CSPG4, ITGB3, PIK3C2A, GHR, BLNK, NCBP2, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, SHCBP1, CD4, CD7, TEK]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[NUP107, SPI1, SLA2, SPIB, AKT1, MNX1, ATF3, CDCA7, GATA3, GATA1, JUN, JAG1, JUP, EIF2AK2, NR2F2, PKIG, HOXC10, CHAF1B, FOS, MMP12, MED23, PLSCR1, PTAFR, SPP1, ZNF467, CASP8AP2, ATAD2, NOC3L, CENPF, PKN1, LGR4, GMNN, EFEMP1, BLM, G3BP2, ZNF423, CIITA, ITGB2, HHEX, UHRF1, CDC45, E2F1, E2F2, E2F5, E2F7, POU2AF1, SMARCAL1, IKZF1, ICAM1, TNFSF11, TRIM25, FBXO5, BTK, TRIB1, TGFA, PKHD1, EGR1, EGR2, EGR3, POLA1, ECM1, IL10, SYK, IL18, IL1A, IL1B, KIT, DEPDC1, YAP1, PCNA, IL33, OSM, ETS1, NR3C2, LOXL2, CARD11, TCF7, HTRA1, LPXN, CAV1, UBA3, TCF4, MXD1, FBN1, PLEK, TNFAIP3, LYL1, MYBL1, MYOCD, NUP133, IRAK3, ETV1, GREM1, ELF3, ZMYND11, FBP1, TBX21, RRM2, CD4, PHB2, PRKCH, PRKCQ, PRKCZ, NUP85, PRDM16, HMOX1, NFE2, PLK1, SNAI2, CDKN1A, BTG2, ZNF367, RARA, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, ELP4, FOSB, PF4, CSF3, PLXND1, TNF, CLU, TLE4, MAP2K2, AEBP1, MAP2K6, DAB2, COPS5, BCL6, BCL3, CCDC22, SLC26A3, CYR61, LBH, EMILIN1, RFC1, TFDP1, XCL1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, NLRC3, NLRC4, NOD2, ABLIM3, POLR2K, POLR2L, PML, DNAJA3, PPIL4, GFI1, PPP2R1A, RPS6KA1, FLT3LG, NIF3L1, IL23A, SIK1, TXK, TWIST1, LIF, TOP2A, AHCTF1, IFNA2, PRL, XPO1, HBZ, EDN1, PARP9, CBFA2T3, VAV1, MLF2, HCK, TLR6, TLR4, TLR2, TYMS, PURA, GRHL2, CD40LG, HOXA11, HOXA10, LMO2, FANCD2, NLRP3, CBX4, KDM5D, SLC40A1, H2AFX, DCN, DNM2, PFDN5, LTF, LEF1, HLX, SNCA, LUM, RBMX, PID1, EHMT2, MEF2A, MEF2C, ZFYVE16, PADI2, PADI4, HESX1, MCTS1, HACE1, COL1A1, EZH2, RIPK2, ACTL6A, SIRT1, PSMA6, CKS2, FSTL1, BTAF1, STAT4, FLNA, USP9Y, PSMC6, PSMC2, CCNT2, NCF1, RORA, RUVBL2, RUVBL1, ADCYAP1, S100A9, S100A8, MAZ, TNFRSF11A, FOXO1, NFKB1, NFKB2, CXCL10, MYD88, FHL2, FASLG, ARRB1, ARRB2, PPP1R12A, PEG3, BIRC5, BDP1, BIRC2, LRP2, PRRX1, CCNH, CCNC, UXT, TMPO, HNF1B, EREG, SFRP4, SFRP2, IFI27, PCBP3, ZNF700, OR7D2, ID1, CD28, CD40, SUV39H1, HNF4G, PTPRK, BRCA1, BRCA2, PCSK6, BMI1, CD3D, HNF4A, CD38, CD36, RGMA, SATB2, RXRA, CD74, NLRP12, NEDD4, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, EOMES, CCNE1, CALCA, VDR, HMGA1, INHBA, IL6, BMP2, HMGB2, ARHGEF10L, AFF3, NUP62, YWHAH, DDX58, CCNA2, PSRC1, IRF7, IRF8, CREB5, TAF9, AURKB, EGF, MAPK14, SOD2, MAPK13, NUP35, TAF5, NAA15, RAN, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, CYP1B1, HOXA7, JUNB, HOXA5, HOXA4, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, RAD21, S100A12, ELANE, NKX2-3, FZD1, FZD5, FZD8, CDC6, TGFB1I1, HAVCR2, BRD2, ANXA3, NFAM1, PAWR, PAX5, PAX2, AES, TAL1, HCLS1, PLCB1, ENG, GTF2H1, SULF1, POU4F1, PYCARD, DACH1, CDH1, MEN1, F2R, ADAM8, NACC2, WFS1, HOPX, MAFB, CNOT3, MAFF, CHUK, TRAF1, SMARCD3, RBBP8, ZNF503, IRX3, KLF4, KLF1, KLF8, KLF6, KLF5, MNDA, ZNF608, EDNRB, CHEK1, DPF3, SOX7, SOX4, SLC11A1, EBF1, RUNX2, PFN1, BEX1, SP140, NHLH2, CDT1, BCL11B, BCL11A, RHOG, RHOH, MDFIC, TFEC, SGK1, SP100, CDX2, CDX1, LILRB1, CAMK4, CAMK1, ARID4A, ARID4B, CHCHD3, BASP1, ADRB2, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, JMY, CREBZF, TMEM100, KLF12, KLF13, CKAP2, TGFBR3, IFNG, CAMK2D, DLL1, HSPD1, MEIS2, MEIS1]
GO:0002431;Fc receptor mediated stimulatory signaling pathway;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;218.73839564357212;4.87179884924204;0.007320977250414979;0.6453846448923425;[CYFIP1, CD3G, IGHG1, FCGR3A, FCER1G, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, PLCG2, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, NR4A3, CD247, FCGR2B, IGKV3-20]
GO:0045634;regulation of melanocyte differentiation;6.0;0.7866048967936545;0.7164227609869718;9.223059144383958;39.03591275187644;7.9853141584524145;0.0013064968697646632;0.7314896500084853;[GNAQ, BCL2, ADAMTS20]
GO:0002553;histamine secretion by mast cell;10.0;1.0;0.9152410118609203;9.628524252492122;188.83492405524427;8.67846133901236;0.006320134967730841;0.8590579283277371;[LYN, BTK]
GO:0050663;cytokine secretion;9.0;0.6056485694559711;0.6990649099082746;8.227631091951078;133.331941423656;5.9928839937622085;0.004462500088492957;0.7027169913188946;[NLRC4, GATA3, NOD2, NLRP3, S100A12, CCR7, ITGB6, CD36, CCL19, LYN, ABCA1, NR1H4, LILRB1, CHI3L1, LCP2, TLR6, TLR4, CARD11, TLR2]
GO:0030316;osteoclast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.375876246018314;0.0015755275618510598;0.6491829203200885;[CSF1R, TGFB1, FCER1G, TFRC, TREM2, TNFRSF11A, GAB2, MAPK14, TNF, OSCAR, TYROBP, TNFSF11, JUNB, EPHA2]
GO:0070372;regulation of ERK1 and ERK2 cascade;10.0;0.8653626801206646;0.8479223519212526;9.541512875502493;158.98679164778278;4.069963362931594;0.0053211448376282704;0.623379127513894;[PHB2, TNF, CTGF, ICAM1, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, ATF3, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FBLN1, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PKHD1, PDGFD, PDGFC, SLAMF1, LYN, CCR1, JUN, TGFB1, LIF, FN1, MARCO, BMP2, NOX4, NRP1, PTPRR, TREM2, PTPN22, ARRB1, ARRB2, CYR61, DUSP10, TIMP3, CCR7, EMILIN1, CD36, HAVCR2, DUSP3, SYK, DUSP1, RIPK2, DUSP6, CEACAM1, IL1B, KIT, XCL2, CHI3L1, XCL1, TLR4, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, KLF4, CD4, NLRP12, PTPN6, TEK]
GO:0019370;leukotriene biosynthetic process;8.0;0.8653626801206646;0.8076813400603323;9.488762310116963;324.40599840797483;6.781341354126479;0.010857576820271119;0.7217981122146513;[SYK, ALOX5]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, RNASE6, RNASE3, MIF, HLA-E, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, RIPK2, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, IGKC, CARD9, NR1H4, KIR3DL1, LGR4, C1QC, FCN1, NCF1, NCF2, SLA, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[PTPRR, FBLN1, ARRB1, DUSP10, TIMP3, CSK, EMILIN1, EPHB2, LYN, DUSP3, DUSP1, LIF, KLF4, DUSP6, NLRP12, TLR4, ATF3]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, NOX1, SRPX, ADM, CTLA4, TIMP3, ANXA1, DUSP1, RIPK2, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, BCL2, BCL2L1, PLEKHF1, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, GZMA, GZMB, PML, P2RX1, MNDA, IFIT2, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, TNFAIP8, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0071226;cellular response to molecule of fungal origin;5.0;1.0;0.7902410118609202;9.628524252492122;58.24779613319063;9.083926447120524;0.00194950131696474;0.7547934328124444;[SYK, BTK]
GO:0033026;negative regulation of mast cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;301.33162323320204;9.777073627680469;0.010085298248760914;0.896240625180289;[FCER1G]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, NOD2, PRKCZ, HSPD1, PYCARD, CD40LG, IL23A, BCL3, CD28, XCL1, TIGIT, TLR4, CD34, TLR2]
